MKI67 and neoplasm: The proliferation index, assessed by Ki-67 immunoreactivity in the viable neoplastic tissue excluding areas of tissue necrosis, was significantly lower (P<0.005) than in ACN/neo tumours (66.5±4.0 vs 80.2±5.4%) (Figure 6C, Ki-67).